Abstract
SEVERAL publications have indicated that in the detoxication of paraoxon (diethyl p-nitrophenyl phosphate, ‘E600,’ ‘Mintacol’) the mammalian blood serum might be of importance1–3. Aldridge4 was first to describe the existence of an A esterase (aryl-, aromatic esterase) which hydrolyses paraoxon. This enzyme occurs in the sera of various species1, but the extent of its involvement in the metabolism of paraoxon is not yet clear5,6. Among other properties, the arylesterase cleaves phenyl acetate7, and it has been shown with this substrate that the enzyme requires the presence of calcium for activity8,9. The arylesterase is activated by calcium and inhibited by sodium ethylenediaminetetraacetate and numerous other compounds8–11. In human blood plasma it occurs in fraction IV–112,13. Since preliminary experiments indicated that in addition to this arylesterase, at least one more factor might be responsible for the hydrolysis of paraoxon in blood serum or plasma, we undertook the present investigations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aldridge, W. N., Biochem. J., 53, 117 (1953).
Friedberg, K. D., and Erdmann, W. D., Arch. Exp. Path. u. Pharmak., 237, 1 (1959).
Schaumann, W., and Schiller, M., Arch. Exp. Path. u. Pharmak., 239, 114 (1960).
Aldridge, W. N., Biochem. J., 53, 110 (1953).
Main, A. R., Biochem. J., 74, 10 (1960).
Main, A. R., Biochem. J., 75, 188 (1960).
Mounter, L. A., and Whittaker, V. P., Biochem. J., 54, 551 (1953).
Erdös, E. G., Debay, C. R., and Westerman, M. P., Nature, 184, 430 (1959).
Erdös, E. G., Debay, C. R., and Westerman, M. P., Biochem. Pharmacol., 5, 173 (1960).
Marton, A., and Kalow, W., Canad. J. Biochem. Physiol., 37, 1367 (1959).
Marton, A. V., and Kalow, W., Biochem. Pharmacol., 3, 149 (1960).
Casida, J. E., and Augustinsson, K.-B., Biochim. Biophys. Acta, 36, 411 (1959).
Erdös, E. G., and Debay, C. R., Biochim. Biophys. Acta, 39, 551 (1960).
Lineweaver, H., and Burk, D., J. Amer. Chem. Soc., 56, 658 (1934).
Augustinsson, K.-B., and Heimbürger, G., Acta Chem. Scand., 9, 383 (1955).
Kewitz, H., Wilson, I. B., and Nachmansohn, D., Arch. Biochem. Biophys., 64, 456 (1956).
Rosenberg, P., Biochem. Pharmacol., 3, 212 (1960).
O'Brien, R. D., Toxic Phosphorus Esters (Academic Press, New York, 1960).
Erdös, E. G. (to be published).
Casida, J. E., Augustinsson, K.-B., and Jonsson, G., J. Econ. Entomol., 53, 205 (1960).
Augustinsson, K.-B., and Casida, J. E., Biochem. Pharmacol., 3, 60 (1959).
Kramer, D. N., and Gamson, R. M., Abstracts of Papers, 138th Meeting Amer. Chem. Soc., New York, Sept. 11–16, 1960, 6c.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ERDÖS, E., BOGGS, L. Hydrolysis of Paraoxon in Mammalian Blood. Nature 190, 716–717 (1961). https://doi.org/10.1038/190716a0
Issue Date:
DOI: https://doi.org/10.1038/190716a0
- Springer Nature Limited
This article is cited by
-
Serum paraoxonase 1 (PON1) measurement: an update
BMC Veterinary Research (2014)
-
In vitro kinetics of nerve agent degradation by fresh frozen plasma (FFP)
Archives of Toxicology (2014)
-
Paraoxonase-1 and clopidogrel efficacy
Nature Medicine (2011)
-
Frequency distribution of the single-nucleotide -108C/T polymorphism at the promoter region of the PON1 gene in Asian Indians and its relationship with coronary artery disease
Journal of Community Genetics (2011)
-
Forensic significance of acetylcholine esterase histochemistry in organophosphate intoxication
Zeitschrift für Rechtsmedizin (1982)